Survival and response to therapy in 139 patients with advanced renal cell carcinoma treated with low-dose IL-2 and IFN alpha: Influence of the prognostic risk at the time of diagnosis / Vaglio, A; Bongiovanni, C; Alberici, F; Manna, C; Passalacqua, R; Buti, S; David, S; Buzio, C. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 21:(2006), pp. 371-371.

Survival and response to therapy in 139 patients with advanced renal cell carcinoma treated with low-dose IL-2 and IFN alpha: Influence of the prognostic risk at the time of diagnosis

Buti S;
2006-01-01

2006
Survival and response to therapy in 139 patients with advanced renal cell carcinoma treated with low-dose IL-2 and IFN alpha: Influence of the prognostic risk at the time of diagnosis / Vaglio, A; Bongiovanni, C; Alberici, F; Manna, C; Passalacqua, R; Buti, S; David, S; Buzio, C. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 21:(2006), pp. 371-371.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2906942
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact